Apremilast Alleviates Severe Psoriasis in Some Children, Data Show

Proportionally more children treated with apremilast than with placebo achieved a Physician's Global Assessment response at week 16, with no new safety concerns highlighted.

Related Keywords

Italy ,Leo Pharma ,Azienda Ospedale Universit ,Anna Belloni Fortina ,Belloni Fortina ,Apremilast Otezla ,European Academy Of Dermatology ,Amgen ,Pfizer ,European Academy ,Global Assessment ,Psoriasis Area ,Severity Index ,Belloni Fontina ,Late Breaking Oral Presentation ,Psoriasis ,Children ,Child ,Childhood ,Ediatrics ,Kids ,Plaque Psoriasis ,Europe ,European ,Severity Indices ,Topical Therapy ,Dermatology Pediatric ,